Title: tizanidineCategory: MedicationsCreated: 6/22/2022 12:00:00 AMLast Editorial Review: 6/22/2022 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 22, 2022 Category: Drugs & Pharmacology Source Type: news
Alembic gets USFDA nod for Tizanidine hydrochloride capsules used to treat spasticity
"The company has received final approval from the US Food& Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tizanidine Hydrochloride Capsules, 2 mg, 4 mg, and 6 mg," the drug firm said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 14, 2020 Category: Pharmaceuticals Source Type: news
Zydus Cadila gets USFDA nod for Tizanidine tablets
The approval by the US Food and Drug Adminstration is for multiple strengths of 2 mg and 4 mg, the company said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 13, 2018 Category: Pharmaceuticals Source Type: news
Unintentional pediatric exposures to central alpha-2 agonists reported to the National Poison Data System - Wang GS, Le Lait MC, Heard K.
OBJECTIVE: To investigate national trends in unintentional pediatric exposures to 3 common alpha-2 agonists: clonidine, guanfacine, and tizanidine. Secondary objectives were to describe outcomes, symptoms, treatments, and death. STUDY DESIGN: Retrospective... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - April 23, 2014 Category: Global & Universal Tags: Age: Infants and Children Source Type: news
Clonidine and other central alpha-2 agonists: can one pill kill a toddler?
3 out of 5 stars Unintentional Pediatric Exposures to Central Alpha-2 Agonists Reported to the National Poison Data System. Wang GS et al. J Pediatr 2013 Oc 1 [Epub ahead of print] Abstract Central alpha-2 agonists — clonidine, guanfacine, and tizanidine — are increasingly being used for approved and off-label indications, including hypertension, muscle spasms, tics, and opioid withdrawal. Extended-release forms of guanfacine (Intuniv) and clonidine (Kapvay) have been approved for treatment of attention-deficit hyperactivity disorder (ADHD). These drugs are selective agonists at the central presynaptic alpha-2 adrener...
Source: The Poison Review - November 9, 2013 Category: Toxicology Authors: Leon Tags: Medical central alpha-2 agonist clonidine guanfacine intuniv kapvay kill one pill pediatric tizanidine Source Type: news
Reddy's Recalls Drug In US On Labeling Errors
Dr Reddy's Laboratories is recalling its muscle relaxant drug, tizanidine, in the US market because of labeling errors. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - April 16, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news
Dr Reddy's Labs recalls muscle relaxant drug from US mkt
Dr Reddy's Laboratories has initiated recall of its tizanidine tablets, used as a muscle relaxant, from the US market due to labelling issues. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 11, 2013 Category: Pharmaceuticals Source Type: news